Literature DB >> 18239622

Preclinical targeting of NF-kappaB and FLT3 pathways in AML cells.

E Griessinger, C Frelin, N Cuburu, V Imbert, C Dageville, M Hummelsberger, N Sirvent, M Dreano, J-F Peyron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18239622     DOI： 10.1038/sj.leu.2405102

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Novel agents inhibit human leukemic cells.

Authors:  Wei-ping Yu; Juan Li
Journal:  Acta Pharmacol Sin       Date:  2012-01-09       Impact factor: 6.150

2.  Overcoming adaptive therapy resistance in AML by targeting immune response pathways.

Authors:  Katelyn Melgar; Morgan M Walker; LaQuita M Jones; Lyndsey C Bolanos; Kathleen Hueneman; Mark Wunderlich; Jian-Kang Jiang; Kelli M Wilson; Xiaohu Zhang; Patrick Sutter; Amy Wang; Xin Xu; Kwangmin Choi; Gregory Tawa; Donald Lorimer; Jan Abendroth; Eric O'Brien; Scott B Hoyt; Ellin Berman; Christopher A Famulare; James C Mulloy; Ross L Levine; John P Perentesis; Craig J Thomas; Daniel T Starczynowski
Journal:  Sci Transl Med       Date:  2019-09-04       Impact factor: 17.956

Review 3.  Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia.

Authors:  Garrett M Dancik; Ioannis F Voutsas; Spiros Vlahopoulos
Journal:  Mol Biol Rep       Date:  2022-01-14       Impact factor: 2.316

Review 4.  Mechanisms of resistance to FLT3 inhibitors.

Authors:  S Haihua Chu; Donald Small
Journal:  Drug Resist Updat       Date:  2009-01-21       Impact factor: 18.500

5.  Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines.

Authors:  Ines Tagoug; Amélie Sauty De Chalon; Charles Dumontet
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

6.  Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia.

Authors:  Naxin Guo; Mitra Azadniv; Myra Coppage; Mary Nemer; Jason Mendler; Michael Becker; Jane Liesveld
Journal:  Transl Oncol       Date:  2019-01-27       Impact factor: 4.243

7.  Antitumor Mechanism of the Essential Oils from Two Succulent Plants in Multidrug Resistance Leukemia Cell.

Authors:  Paola Poma; Manuela Labbozzetta; James A McCubrey; Aro Vonjy Ramarosandratana; Maurizio Sajeva; Pietro Zito; Monica Notarbartolo
Journal:  Pharmaceuticals (Basel)       Date:  2019-08-26

8.  miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR.

Authors:  Yong-Jing Tang; Wei Wu; Qiao-Qian Chen; Shu-Han Liu; Zhi-Yuan Zheng; Zhao-Lei Cui; Jian-Ping Xu; Yan Xue; Dong-Hong Lin
Journal:  BMC Cancer       Date:  2022-08-20       Impact factor: 4.638

9.  Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.

Authors:  Akram Mohammed; Greyson Biegert; Jiri Adamec; Tomáš Helikar
Journal:  Oncotarget       Date:  2017-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.